| Quarterly Financials | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 317 | 299 | 314 | 358 | 353 | 413 | 479 | 517 | 540 |
| Expenses | 257 | 234 | 244 | 286 | 273 | 318 | 367 | 395 | 405 |
| EBITDA | 61 | 64 | 70 | 73 | 80 | 95 | 112 | 121 | 135 |
| Operating Profit % | 19 % | 21 % | 22 % | 20 % | 22 % | 23 % | 23 % | 23 % | 24 % |
| Depreciation | 9 | 8 | 9 | 10 | 10 | 12 | 12 | 12 | 15 |
| Interest | 10 | 7 | 8 | 12 | 11 | 11 | 10 | 10 | 9 |
| Profit Before Tax | 41 | 49 | 53 | 51 | 60 | 72 | 91 | 99 | 110 |
| Tax | 16 | 15 | 15 | 15 | 16 | 18 | 18 | 22 | 26 |
| Net Profit | 26 | 35 | 38 | 36 | 43 | 54 | 73 | 77 | 85 |
| EPS in ₹ | 1.66 | 2.27 | 2.50 | 2.37 | 2.81 | 3.49 | 4.46 | 4.68 | 5.13 |
Rubicon Research
Rubicon Research
1,835.40
+45.40
(2.54%)
Market Cap
30,354.35 Cr
PE Ratio
102.85
Volume
3,18,589.00
Day High - Low
1,848.60 - 1,758.10
52W High-Low
1,899.00 - 570.75
Key Fundamentals
Market Cap
30,354.35 Cr
EPS
15.52
PE Ratio
102.85
PB Ratio
23.00
Book Value
77.86
EBITDA
408.00
Dividend Yield
0.08 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
19.14
Debt to Equity
0.40
Analyst Rating and Forecast
- By Refinitiv from2 analysts
Actual
Company News
View All News
Promoter General Atlantic Singapore RR Pte. Ltd. disposed of 1.4 crore shares (8.45%) in Rubicon Research Ltd on Aug 25-26, 2026, reducing its holding to 27.34%.
Rubicon Research AGM: FY26 results, merger
Aug 26, 2026
Aug 26, 2026Rubicon Research held its 27th AGM on August 26, 2026. Shareholders approved FY26 financials, a stock option plan, and the merger of subsidiary KIA Health Tech. Revenue rose 37% to ₹17,540 Mn.
Rubicon Research Q1FY26 Results FiledAug 15, 2026
Aug 15, 2026Rubicon Research Limited has filed its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with BSE and NSE.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,840.00 | #1 4,41,477.63 | 36.91 | #1 61,673.90 | 12.69 | #1 11,565 | 26.53 | 34.00 | |
9,322.00 | 2,47,469.81 | 85.36 | 11,067.00 | 13.95 | 2,568 | 65.50 | 63.65 | |
4,965.50 | 1,88,871.66 | 86.95 | 13,886.20 | 20.34 | 2,138 | 3.28 | 52.16 | |
1,119.10 | 1,12,607.65 | 24.28 | 27,657.90 | 17.64 | 5,026 | -34.90 | 45.64 | |
1,366.00 | 1,10,351.67 | 33.22 | 29,044.60 | 2.24 | 3,870 | -39.18 | 35.27 | |
1,969.00 | 1,06,297.76 | 95.94 | 6,867.80 | 22.01 | 890 | #1 123.93 | 68.28 | |
1,165.50 | 97,280.68 | 29.91 | 35,058.60 | 3.90 | 4,158 | -69.10 | 47.72 | |
1,679.80 | 96,651.98 | 25.88 | 34,145.20 | 5.56 | 3,503 | 25.21 | 57.04 | |
2,095.00 | 95,790.22 | #1 17.09 | 29,038.90 | #1 26.75 | 5,356 | 16.00 | 28.17 | |
2,280.00 | 94,163.08 | 44.87 | 14,636.40 | 14.85 | 1,938 | 29.13 | 37.57 |
Growth Rate
Revenue Growth
36.79 %
Net Income Growth
83.56 %
Cash Flow Change
28.82 %
ROE
-22.95 %
ROCE
-30.01 %
EBITDA Margin (Avg.)
11.35 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 430 | 538 | 560 | 750 | 1,110 | 1,451 | 2,327 |
| Fixed Assets | 157 | 188 | 193 | 199 | 307 | 327 | 532 |
| Current Assets | 265 | 340 | 328 | 502 | 763 | 1,063 | 1,682 |
| Capital Work in Progress | 2 | 6 | 3 | 25 | 10 | 7 | 41 |
| Investments | 19 | 14 | 0 | 0 | 0 | 0 | 27 |
| Other Assets | 252 | 331 | 364 | 526 | 793 | 1,118 | 1,728 |
| Total Equity & Liabilities | 430 | 538 | 560 | 750 | 1,110 | 1,451 | 2,327 |
| Current Liabilities | 78 | 111 | 184 | 361 | 573 | 786 | 836 |
| Non Current Liabilities | 12 | 53 | 71 | 102 | 152 | 124 | 202 |
| Total Equity | 341 | 374 | 305 | 286 | 385 | 541 | 1,289 |
| Reserve & Surplus | 335 | 369 | 300 | 281 | 370 | 526 | 1,272 |
| Share Capital | 5 | 5 | 5 | 5 | 15 | 15 | 17 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | 1 | 67 | -46 | 16 | -4 | 54 | 81 |
| Investing Activities | -84 | -46 | -46 | -32 | -68 | -65 | -407 |
| Operating Activities | 6 | 62 | -63 | -75 | 21 | 159 | 205 |
| Financing Activities | 80 | 52 | 63 | 123 | 44 | -40 | 283 |
Share Holding
| % Holding | Jul 2024 | Sept 2025 | Oct 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 84.15 % | 59.99 % | 59.99 % | 59.99 % | 59.86 % | 59.76 % |
| FIIs | 0.00 % | 9.37 % | 9.37 % | 7.99 % | 7.54 % | 7.52 % |
| DIIs | 0.00 % | 10.54 % | 10.54 % | 9.45 % | 10.02 % | 9.43 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 18.28 % | 18.28 % | 2.71 % | 2.82 % | 3.46 % |
| Others | 15.85 % | 1.82 % | 1.82 % | 19.86 % | 19.76 % | 19.84 % |
| No of Share Holders | 15 | 1,05,311 | 1,05,311 | 31,914 | 33,738 | 43,254 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 1.5 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 13 Nov 2025 |  Quarterly Result Announcement | NA | 13 Nov 2025 | 638.50 | 627.25 |
| 03 Feb 2026 | Quarterly Result Announcement | NA | 03 Feb 2026 | 650.05 | 688.90 |
| 29 May 2026 | Quarterly Result Announcement | NA | 29 May 2026 | 969.10 | 967.90 |
| 07 Aug 2026 |  Dividend | ₹ 1.50 /share | 07 Aug 2026 | 967.90 | 1,533.05 |
| 14 Aug 2026 | Quarterly Result Announcement | NA | 14 Aug 2026 | 1,533.05 | 1,620.70 |
| 26 Aug 2026 |  Annual General Meeting | NA | 26 Aug 2026 | 1,440.20 | 1,708.80 |
Announcements
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 29, 2026
Aug 29, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 27, 2026
Aug 27, 2026Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 26, 2026
Aug 26, 2026Shareholder Meeting / Postal Ballot-Outcome of AGMAug 26, 2026
Aug 26, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 19, 2026
Aug 19, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 15, 2026
Aug 15, 2026Audio Recording Of Earnings Conference Call For The Quarter Ended 30Th June 2026.Aug 14, 2026
Aug 14, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 14, 2026
Aug 14, 2026Announcement under Regulation 30 (LODR)-Change in ManagementAug 14, 2026
Aug 14, 2026Announcement under Regulation 30 (LODR)-Investor PresentationAug 14, 2026
Aug 14, 2026Board Meeting Outcome for Unaudited Financials Results For Quarter Ended June 30 2026Aug 14, 2026
Aug 14, 2026Reg. 34 (1) Annual Report.Aug 13, 2026
Aug 13, 2026Reg. 34 (1) Annual Report.Aug 11, 2026
Aug 11, 2026Earnings Conference CallAug 07, 2026
Aug 07, 2026Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2026Aug 07, 2026
Aug 07, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 04, 2026
Aug 04, 2026Business Responsibility and Sustainability Reporting (BRSR)Aug 03, 2026
Aug 03, 2026Notice Of 27Th Annual General Meeting Along With Integrated Annual Report Of The Company For The Financial Year 2025-26 And Letter For Weblink To Access Notice And The Integrated Annual ReportAug 03, 2026
Aug 03, 2026Newspaper Advertisement Titled Information Regarding 27Th Annual General Meeting To Be Held Through Video Conferencing/ Other Audio-Visual Means Final Dividend And Record Date InformationJul 30, 2026
Jul 30, 2026Communication On Tax Deduction At Source On DividendJul 29, 2026
Jul 29, 2026Filing Of Scheme Of Merger Of Kia Health Tech Private Limited (Wholly Owned Subsidiary) With Rubicon Research Limited - For Disclosure Purposes Only In Terms Of The Exemption Under Paragraph 4 Of SEBI Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 DaJul 22, 2026
Jul 22, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 22, 2026
Jul 22, 2026Record Date For Payment Of Final Dividend - Friday August 7 2026Jul 20, 2026
Jul 20, 2026Outcome Of Board MeetingJul 20, 2026
Jul 20, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 20, 2026
Jul 20, 2026Certificate Under Regulation 74(5) Of SEBI (Depositories And Participants) Regulations 2018 For The Quarter Ended June 30 2026.Jul 09, 2026
Jul 09, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - US FDA Inspection Of The CompanyS Manufacturing Facility In Pithampur Madhya PradeshJul 03, 2026
Jul 03, 2026Closure of Trading WindowJun 29, 2026
Jun 29, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 02, 2026
Jun 02, 2026Earnings Call Audio RecordingMay 30, 2026
May 30, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2026
May 30, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 29, 2026
May 29, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2026
May 29, 2026Statement On Deviation/Variation Of Funds And Further Extension Of Timeline For Utilization Of IPO Proceeds.May 29, 2026
May 29, 2026Corporate Action-Board approves DividendMay 29, 2026
May 29, 2026Formulation And Adoption Of New Employee Benefit PlanMay 29, 2026
May 29, 2026Audited Financial Results For The Quarter And Year Ended 31 March 2026 And Recommendation Of DividendMay 29, 2026
May 29, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 29, 2026
May 29, 2026Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended March 31 2026 And Recommendation Of DividendMay 29, 2026
May 29, 2026Earnings Conference CallMay 25, 2026
May 25, 2026Board Meeting Intimation for Intimation Of Board MeetingMay 22, 2026
May 22, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2026
May 15, 2026Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) - Completion Of Acquisition Of Securities In Arinna Lifesciences LimitedApr 30, 2026
Apr 30, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 27, 2026
Apr 27, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Outcome Of USFDA Inspection At The CompanyS R&D Facility In CanadaApr 24, 2026
Apr 24, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Outcome Of USFDA Inspection At The CompanyS R&D Facility In CanadaApr 24, 2026
Apr 24, 2026Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Apr 22, 2026
Apr 22, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 15, 2026
Apr 15, 2026Announcement under Regulation 30 (LODR)-AcquisitionApr 15, 2026
Apr 15, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 13, 2026
Apr 13, 2026Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 59.95
ATR(14)
Volatile 74.96
STOCH(9,6)
Neutral 45.68
STOCH RSI(14)
Neutral 24.88
MACD(12,26)
Bearish -9.36
ADX(14)
Strong Trend 29.43
UO(9)
Bearish 51.58
ROC(12)
Uptrend And Accelerating 0.91
WillR(14)
Neutral -31.21
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
